← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:1126 | 1126 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fluocinolone Acetonide; Hydroquinone; Tretinoin | 2019-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2019-2:1126 | 1126 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2020-1:1126 | 1126 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-100 | 70004-100-16 | Morphine Sulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1126 | 1126 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-110 | 70004-110-59 | Morphine Sulfate | 2020-2 | valid | 0 | 2026-10-20 | |
outsourcing:2021-1:1126 | 1126 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-2:1126 | 1126 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-1:1126 | 1126 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-2:1126 | 1126 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-005 | 73198-005-05 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1126 | 1126 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2023-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2023-2:1126 | 1126 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-1115 | 26436-1115-1 | Oxandrolone | 2023-2 | valid | 0 | 2026-10-20 | |
outsourcing:2024-1:1126 | 1126 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-001 | 71449-001-15 | Phenylephrine Hydrochloride | 2024-1 | valid | 0 | 2026-10-20 | |
outsourcing:2024-2:1126 | 1126 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-957 | 69374-957-10 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1126 | 1126 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-122 | 73702-122-03 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-20 | |
outsourcing:2025-2:1126 | 1126 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Acetate; Moxifloxacin Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2026-1:1126 | 1126 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 54288-840 | 54288-840-25 | Pyridoxine Hydrochloride; Tirzepatide | 2026-1 | valid | 0 | 2026-10-20 | |
compounder:1127 | 1127 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3010 | 79559-3010-1 | S-E010 | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1127 | 1127 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fluocinonide | 2019-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2019-2:1127 | 1127 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2020-1:1127 | 1127 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-100 | 70004-100-63 | Morphine Sulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1127 | 1127 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-110 | 70004-110-62 | Morphine Sulfate | 2020-2 | valid | 0 | 2026-10-20 | |
outsourcing:2021-1:1127 | 1127 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-2:1127 | 1127 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-1:1127 | 1127 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-2:1127 | 1127 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-014 | 73198-014-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1127 | 1127 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0012 | 71139-0012-1 | Oxytocin | 2023-1 | valid | 0 | 2026-10-20 | |
outsourcing:2023-2:1127 | 1127 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-068 | 70092-068-07 | Oxytocin | 2023-2 | valid | 0 | 2026-10-20 | |
outsourcing:2024-1:1127 | 1127 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-2:1127 | 1127 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-112 | 73177-112-03 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1127 | 1127 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-125 | 73702-125-10 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-20 | |
outsourcing:2025-2:1127 | 1127 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Acetate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 2025-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2026-1:1127 | 1127 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8120 | 71266-8120-1 | Racepinephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-20 | |
compounder:1128 | 1128 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-8104 | 70168-8104-1 | Testosterone 70mg | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1128 | 1128 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fluocinonide | 2019-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2019-2:1128 | 1128 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2020-1:1128 | 1128 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-100 | 70004-100-62 | Morphine Sulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1128 | 1128 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-110 | 70004-110-18 | Morphine Sulfate | 2020-2 | valid | 0 | 2026-10-20 | |
outsourcing:2021-1:1128 | 1128 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 51754-9131 | 51754-9131-1 | Midazolam Hydrochloride | 2021-1 | valid | 0 | 2026-10-20 | |
outsourcing:2021-2:1128 | 1128 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-1:1128 | 1128 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-2:1128 | 1128 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-014 | 73198-014-05 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1128 | 1128 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2023-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2023-2:1128 | 1128 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-012 | 68985-012-93 | Oxytocin | 2023-2 | valid | 0 | 2026-10-20 | |
outsourcing:2024-1:1128 | 1128 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-010 | 71506-010-58 | Phenylephrine Hydrochloride | 2024-1 | valid | 0 | 2026-10-20 | |
outsourcing:2024-2:1128 | 1128 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-001 | 71449-001-11 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1128 | 1128 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-125 | 73702-125-15 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-20 | |
outsourcing:2025-2:1128 | 1128 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Acetate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 2025-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2026-1:1128 | 1128 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-088 | 73198-088-10 | Riboflavin 5'-Phosphate Sodium; Ascorbic Acid; Magnesium Chloride; Dexpanthenol; Niacinamide; Calcium Gluconate; Pyridoxine Hydrochloride; Thiamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-20 | |
compounder:1129 | 1129 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6726 | 71300-6726-2 | Lidocaine | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1129 | 1129 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fluocinonide | 2019-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2019-2:1129 | 1129 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2020-1:1129 | 1129 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-100 | 70004-100-30 | Morphine Sulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1129 | 1129 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-110 | 70004-110-63 | Morphine Sulfate | 2020-2 | valid | 0 | 2026-10-20 | |
outsourcing:2021-1:1129 | 1129 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-2:1129 | 1129 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-1:1129 | 1129 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-2:1129 | 1129 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-014 | 73198-014-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1129 | 1129 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2023-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2023-2:1129 | 1129 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6044 | 71285-6044-1 | Oxytocin | 2023-2 | valid | 0 | 2026-10-20 | |
outsourcing:2024-1:1129 | 1129 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-040 | 71506-040-10 | Phenylephrine Hydrochloride | 2024-1 | valid | 0 | 2026-10-20 | |
outsourcing:2024-2:1129 | 1129 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-001 | 71449-001-15 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1129 | 1129 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-001 | 71449-001-11 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-20 | |
outsourcing:2025-2:1129 | 1129 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9055 | 83826-9055-5 | Prednisolone Sodium Phosphate; Bromfenac Sodium | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1129 | 1129 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5471 | 26436-5471-3 | Riboflavin 5'-Phosphate Sodium; Niacinamide; Pyridoxine Hydrochloride; Thiamine Hydrochloride | 2026-1 | valid | 0 | 2026-10-20 | |
compounder:1130 | 1130 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-113 | 73702-113-53 | Neostigmine Methylsulfate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1130 | 1130 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fluocinonide | 2019-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2019-2:1130 | 1130 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2020-1:1130 | 1130 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-100 | 70004-100-59 | Morphine Sulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1130 | 1130 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1050 | 5446-1050-01 | Moxifloxacin | 2020-2 | valid | 0 | 2026-10-20 | |
outsourcing:2021-1:1130 | 1130 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-2:1130 | 1130 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-1:1130 | 1130 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-2:1130 | 1130 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-013 | 73198-013-05 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1130 | 1130 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2023-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2023-2:1130 | 1130 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6039 | 71285-6039-1 | Oxytocin | 2023-2 | valid | 0 | 2026-10-20 | |
outsourcing:2024-1:1130 | 1130 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-024 | 71506-024-58 | Phenylephrine Hydrochloride | 2024-1 | valid | 0 | 2026-10-20 | |
outsourcing:2024-2:1130 | 1130 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-506 | 65302-506-10 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1130 | 1130 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9011 | 71266-9011-1 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-20 | |
outsourcing:2025-2:1130 | 1130 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-009 | 81375-009-05 | Prednisolone Sodium Phosphate; Bromfenac Sodium | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1130 | 1130 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-129 | 73702-129-15 | Rocuronium | 2026-1 | valid | 0 | 2026-10-20 | |
compounder:1131 | 1131 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7022 | 71285-7022-1 | Heparin 4000units added to NS | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1131 | 1131 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fluocinonide | 2019-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2019-2:1131 | 1131 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2020-1:1131 | 1131 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-022 | 71449-022-32 | Morphine Sulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1131 | 1131 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin | 2020-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-1:1131 | 1131 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-2:1131 | 1131 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-1:1131 | 1131 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-2:1131 | 1131 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-013 | 73198-013-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1131 | 1131 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-5030 | 70214-5030-1 | Oxytocin | 2023-1 | valid | 0 | 2026-10-20 | |
outsourcing:2023-2:1131 | 1131 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2023-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-1:1131 | 1131 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-008 | 71506-008-58 | Phenylephrine Hydrochloride | 2024-1 | valid | 0 | 2026-10-20 | |
outsourcing:2024-2:1131 | 1131 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1418 | 61141-1418-1 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1131 | 1131 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2025-2:1131 | 1131 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-002 | 81375-002-05 | Prednisolone Sodium Phosphate; Bromfenac Sodium | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1131 | 1131 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9005 | 71266-9005-5 | Rocuronium Bromide | 2026-1 | valid | 0 | 2026-10-20 | |
compounder:1132 | 1132 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6375 | 72934-6375-2 | Katarya Emulsion | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1132 | 1132 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fluocinonide | 2019-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2019-2:1132 | 1132 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2020-1:1132 | 1132 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-021 | 71449-021-11 | Morphine Sulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1132 | 1132 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin | 2020-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-1:1132 | 1132 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 51754-9131 | 51754-9131-5 | Midazolam Hydrochloride | 2021-1 | valid | 0 | 2026-10-20 | |
outsourcing:2021-2:1132 | 1132 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-1:1132 | 1132 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-2:1132 | 1132 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-011 | 73198-011-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1132 | 1132 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2023-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2023-2:1132 | 1132 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-004 | 72055-004-01 | Oxytocin | 2023-2 | valid | 0 | 2026-10-20 | |
outsourcing:2024-1:1132 | 1132 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-2:1132 | 1132 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2025-1:1132 | 1132 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-7084 | 71139-7084-1 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-20 | |
outsourcing:2025-2:1132 | 1132 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-200 | 81375-200-05 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1132 | 1132 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2002 | 71266-2002-9 | Rocuronium Bromide | 2026-1 | valid | 0 | 2026-10-20 | |
compounder:1133 | 1133 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0111 | 72196-0111-1 | Induction 4 to1 High K (50 mEq) In Plasmalyte A, ph 7.4 with Tromethamine 500ml Bag | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1133 | 1133 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fluocinonide | 2019-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2019-2:1133 | 1133 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2020-1:1133 | 1133 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-6 | Morphine Sulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1133 | 1133 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8604 | 71266-8604-1 | Moxifloxacin Hydrochloride | 2020-2 | valid | 0 | 2026-10-20 | |
outsourcing:2021-1:1133 | 1133 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-2:1133 | 1133 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-1:1133 | 1133 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-2:1133 | 1133 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-011 | 73198-011-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1133 | 1133 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2023-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2023-2:1133 | 1133 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5102 | 71266-5102-1 | Oxytocin | 2023-2 | valid | 0 | 2026-10-20 | |
outsourcing:2024-1:1133 | 1133 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-026 | 71506-026-51 | Phenylephrine Hydrochloride | 2024-1 | valid | 0 | 2026-10-20 | |
outsourcing:2024-2:1133 | 1133 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-166 | 73177-166-25 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1133 | 1133 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2025-2:1133 | 1133 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9033 | 83826-9033-5 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1133 | 1133 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2002 | 71266-2002-1 | Rocuronium Bromide | 2026-1 | valid | 0 | 2026-10-20 | |
compounder:1134 | 1134 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-4002 | 73013-4002-2 | Ropivacaine HCl | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1134 | 1134 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fluorouracil | 2019-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2019-2:1134 | 1134 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2020-1:1134 | 1134 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-1 | Morphine Sulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1134 | 1134 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-096 | 71449-096-42 | Moxifloxacin Hydrochloride | 2020-2 | valid | 0 | 2026-10-20 | |
outsourcing:2021-1:1134 | 1134 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-2:1134 | 1134 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4035 | 71286-4035-2 | Midazolam Hydrochloride | 2021-2 | valid | 0 | 2026-10-20 | |
outsourcing:2022-1:1134 | 1134 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-2:1134 | 1134 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-022 | 73198-022-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1134 | 1134 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6038 | 71285-6038-1 | Oxytocin | 2023-1 | valid | 0 | 2026-10-20 | |
outsourcing:2023-2:1134 | 1134 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2023-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-1:1134 | 1134 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-001 | 71449-001-11 | Phenylephrine Hydrochloride | 2024-1 | valid | 0 | 2026-10-20 | |
outsourcing:2024-2:1134 | 1134 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-505 | 65302-505-10 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1134 | 1134 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2025-2:1134 | 1134 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-300 | 81375-300-08 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1134 | 1134 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-0651 | 83863-0651-1 | Rocuronium Bromide | 2026-1 | valid | 0 | 2026-10-20 | |
compounder:1135 | 1135 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-114 | 70092-114-50 | Hydromorph PF 0.2 mg/ml 50ml NS syr | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1135 | 1135 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fluorouracil | 2019-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2019-2:1135 | 1135 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2020-1:1135 | 1135 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-4 | Morphine Sulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1135 | 1135 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-097 | 71449-097-42 | Moxifloxacin Hydrochloride | 2020-2 | valid | 0 | 2026-10-20 | |
outsourcing:2021-1:1135 | 1135 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-2:1135 | 1135 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4035 | 71286-4035-5 | Midazolam Hydrochloride | 2021-2 | valid | 0 | 2026-10-20 | |
outsourcing:2022-1:1135 | 1135 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Atropine Sulfate; Papaverine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-2:1135 | 1135 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-022 | 73198-022-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1135 | 1135 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6039 | 71285-6039-1 | Oxytocin | 2023-1 | valid | 0 | 2026-10-20 | |
outsourcing:2023-2:1135 | 1135 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2023-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-1:1135 | 1135 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-049 | 68985-049-91 | Phenylephrine Hydrochloride | 2024-1 | valid | 0 | 2026-10-20 | |
outsourcing:2024-2:1135 | 1135 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-174 | 63037-174-25 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1135 | 1135 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-047 | 71506-047-10 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-20 | |
outsourcing:2025-2:1135 | 1135 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-300 | 81375-300-05 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1135 | 1135 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2026-1 | source_no_ndc | 1 | 2026-10-20 | |||
compounder:1136 | 1136 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7022 | 71285-7022-1 | Heparin 4000units added to NS | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1136 | 1136 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fluorouracil | 2019-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2019-2:1136 | 1136 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2020-1:1136 | 1136 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-100 | 70004-100-18 | Morphine Sulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1136 | 1136 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-1:1136 | 1136 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-2:1136 | 1136 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-130 | 71449-130-32 | Midazolam Hydrochloride | 2021-2 | valid | 0 | 2026-10-20 | |
outsourcing:2022-1:1136 | 1136 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Atropine Sulfate; Papaverine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-2:1136 | 1136 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-013 | 73198-013-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1136 | 1136 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6042 | 71285-6042-1 | Oxytocin | 2023-1 | valid | 0 | 2026-10-20 | |
outsourcing:2023-2:1136 | 1136 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2023-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-1:1136 | 1136 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7039 | 71285-7039-1 | Phenylephrine Hydrochloride | 2024-1 | valid | 0 | 2026-10-20 | |
outsourcing:2024-2:1136 | 1136 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-173 | 63037-173-25 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1136 | 1136 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-033 | 71506-033-58 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-20 | |
outsourcing:2025-2:1136 | 1136 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-6028 | 26436-6028-3 | Procaine Hydrochloride | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1136 | 1136 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-155 | 63037-155-25 | Rocuronium Bromide | 2026-1 | valid | 0 | 2026-10-20 | |
compounder:1137 | 1137 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-486 | 70092-486-46 | Phenylephrine 80 mcg/ml in 10ml NS syr | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1137 | 1137 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fluorouracil | 2019-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2019-2:1137 | 1137 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2020-1:1137 | 1137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-3 | Morphine Sulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1137 | 1137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8602 | 71266-8602-1 | Moxifloxacin Hydrochloride | 2020-2 | valid | 0 | 2026-10-20 | |
outsourcing:2021-1:1137 | 1137 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Mirtazapine | 2021-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2021-2:1137 | 1137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-411 | 70004-411-56 | Midazolam Hydrochloride | 2021-2 | valid | 0 | 2026-10-20 | |
outsourcing:2022-1:1137 | 1137 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Papaverine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-2:1137 | 1137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-009 | 73198-009-03 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 | |
outsourcing:2023-1:1137 | 1137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6037 | 72196-6037-1 | Oxytocin | 2023-1 | valid | 0 | 2026-10-20 | |
outsourcing:2023-2:1137 | 1137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-157 | 71449-157-70 | Oxytocin | 2023-2 | valid | 0 | 2026-10-20 | |
outsourcing:2024-1:1137 | 1137 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2024-2:1137 | 1137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6058 | 72196-6058-1 | Phenylephrine Hydrochloride | 2024-2 | valid | 0 | 2026-10-20 | |
outsourcing:2025-1:1137 | 1137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-031 | 71506-031-51 | Phenylephrine Hydrochloride | 2025-1 | valid | 0 | 2026-10-20 | |
outsourcing:2025-2:1137 | 1137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-3030 | 70168-3030-1 | Progesterone | 2025-2 | valid | 0 | 2026-10-20 | |
outsourcing:2026-1:1137 | 1137 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-156 | 63037-156-25 | Rocuronium Bromide | 2026-1 | valid | 0 | 2026-10-20 | |
compounder:1138 | 1138 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0061 | 70168-0061-1 | Testo70mgCHOL | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1138 | 1138 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fluorouracil | 2019-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2019-2:1138 | 1138 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-022 | 71449-022-32 | Morphine Sulfate | 2019-2 | valid | 0 | 2026-10-20 | |
outsourcing:2020-1:1138 | 1138 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-6795 | 60652-6795-2 | Morphine Sulfate | 2020-1 | valid | 0 | 2026-10-20 | |
outsourcing:2020-2:1138 | 1138 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8603 | 71266-8603-1 | Moxifloxacin Hydrochloride | 2020-2 | valid | 0 | 2026-10-20 | |
outsourcing:2021-1:1138 | 1138 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1011 | 5446-1011-01 | Mitomycin | 2021-1 | valid | 0 | 2026-10-20 | |
outsourcing:2021-2:1138 | 1138 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-411 | 70004-411-59 | Midazolam Hydrochloride | 2021-2 | valid | 0 | 2026-10-20 | |
outsourcing:2022-1:1138 | 1138 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Papaverine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-20 | |||
outsourcing:2022-2:1138 | 1138 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-009 | 73198-009-10 | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2022-2 | valid | 0 | 2026-10-20 |